Arrhythmias, Cardiac
10 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Cardiovascular Diseases, Heart Diseases
Narrower: Atrial Fibrillation 7, Tachycardia, Ventricular 1, Ventricular Fibrillation 1
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Amrecibart for atrial fibrillation | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Cenvacibart for atrial fibrillation | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Echocardiography + Electrocardiogram (ECG) + DEFERIPRONE + Deferoxamine + Deferasirox for arrhythmias, cardiac | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Finerenone for atrial fibrillation | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| L-PSGB first for tachycardia, ventricular | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| L-PSGB first for ventricular fibrillation | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Medical or interventional therapy for rhythm control in atrial fibrillation (antiarrhythmic drugs, ablation, electric cardio version) for atrial fibrillation | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| pharmacogenetic algorithm for atrial fibrillation | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Prasugrel or Ticagrelor for atrial fibrillation | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Semaglutide for atrial fibrillation | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.